# Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases

> **NCT02925351** · EARLY_PHASE1 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Autoimmune Disease
- Crohn Disease
- Inflammatory Disorder
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Takayasu Arteritis

## Interventions

- **PROCEDURE:** Computed Tomography
- **RADIATION:** Fluorine F 18 Clofarabine
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT02925351
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-25
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02925351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02925351, "Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02925351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*